+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06919744

Evaluating Transverse Venous Sinus Stenting Compared to Standard Medical Treatment in Newly Diagnosed Idiopathic Intracranial Hypertension Patients

Led by University Hospital, Montpellier · Updated on 2025-10-03

114

Participants Needed

3

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating treatments for patients recently diagnosed with idiopathic intracranial hypertension IIH, a condition marked by increased pressure inside the skull that causes symptoms like vision loss, chronic headaches, and ringing in the ears. This trial aims to determine whether placing a stent in a narrowed vein in the brain can better reduce this pressure and improve symptoms compared to standard medical care alone. The study involves patients with specific vein narrowing diagnosed within the last three months. Participants will be randomly assigned to one of two groups one receiving best medical care, which includes medication called acetazolamide and recommended weight loss and the other receiving the same medical care plus a stenting procedure in the transverse venous sinus, a vein in the brain. The stenting is performed by a neuro-radiological intervention. Follow-up visits are scheduled at 1, 3, and 12 months after treatment to monitor progress. During the study, patients will undergo eye exams and imaging tests to assess symptoms like papilledema swelling of the optic nerve, headaches, and visual function. Researchers will measure how many patients have resolved papilledema and normalized intracranial pressure after 3 months, along with additional assessments of headache severity, tinnitus, vision, autonomy, and cognition over 12 months. Safety and adherence to treatments will be monitored throughout the trial, which is sponsored by the University Hospital, Montpellier.

CONDITIONS

Brief Title

Intracranial Venous Stenting Evaluation in Patients With Idiopathic Intracranial Hypertension in the Early Phase

Research Team

A

Anne DUCROS, MD, PhD

F

Fédérico CAGNAZZO, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here